Min Yao
1
Evelyn Ullrich
2
Adriana Albini
3*The final, formatted version of the article will be published soon.
EDITORIAL article
Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 15 - 2024 |
doi: 10.3389/fimmu.2024.1466010
This article is part of the Research Topic Women in Cancer Immunity and Immunotherapy View all 10 articles
Editorial: Women in Cancer Immunity and Immunotherapy
Provisionally accepted- 1 Nantong University, Nantong, Jiangsu Province, China
- 2 Goethe Institute, Münich, Germany
- 3 European Institute of Oncology IEO (IRCCS), Milan, Italy
Keywords: cancer immunity, Immunotherapy, Women, immunology, Vaccines
Received: 17 Jul 2024; Accepted: 01 Aug 2024.
Copyright: © 2024 Yao, Ullrich and Albini. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Adriana Albini, European Institute of Oncology IEO (IRCCS), Milan, Italy
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.